drugset
drugset / Trial / NCT05299099

Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301

NCT05299099 ↗

Phase 3 Completed 60 enrolled HK inno.N Corporation
RandomizedParallel-groupOpen-labelSupportive care

Summary

This study is designed to evaluate the safety and efficacy of IN-C006 inj. and RCN301 in postoperative patients requiring central parenteral nutrition.

Timeline

Start
2022-05-04
Primary completion
2022-12-09
Completion
2022-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject IN-C006 inj. Unknown 1970 ml Other
Comparator RCN301 Unknown 1820 ml Other

Indications

No indication recorded.